Maxime Dely/LinkedIn
Sep 29, 2025, 16:16
Maxime Dely: Improving Collections for Better Patient Outcomes
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared on LinkedIn:
“Train, refresh, share: Improving Collections for Better Patient Outcomes
We recently had the pleasure of leading a training session at the 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁 𝗝𝘂𝗹𝗲𝘀 𝗕𝗼𝗿𝗱𝗲𝘁 𝗶𝗻 𝗕𝗿𝘂𝘀𝘀𝗲𝗹𝘀, in collaboration with the Cytapheresis team, with my colleague Lieve Dewaegheneire.
- 𝗠𝗮𝗶𝗻 𝗳𝗼𝗰𝘂𝘀: 𝘱𝘦𝘳𝘪𝘱𝘩𝘦𝘳𝘢𝘭 𝘴𝘵𝘦𝘮 𝘤𝘦𝘭𝘭 𝘤𝘰𝘭𝘭𝘦𝘤𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘊𝘈𝘙-𝘛 𝘤𝘦𝘭𝘭𝘴 — two fast-growing areas at the heart of innovative therapies.
Why are these trainings so crucial?
- 𝗥𝗲𝘃𝗶𝘀𝗶𝘁𝗶𝗻𝗴 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝘁𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀: simple reminders that improve collection quality and yields.
- 𝗦𝗵𝗮𝗿𝗶𝗻𝗴 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝘁𝗶𝗽𝘀 from the field to optimize every procedure.
- 𝗘𝗻𝗰𝗼𝘂𝗿𝗮𝗴𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗲𝘅𝗰𝗵𝗮𝗻𝗴𝗲 among professionals to grow and progress together.
In a context where technologies evolve rapidly, investing in training and retraining means:
- 𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲
- 𝗘𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝘀𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆
- And above all, securing the 𝗯𝗲𝘀𝘁 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁 𝗳𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀.
A big thank you to the teams at Institut Jules Bordet and Cytapheresis for their warm welcome and strong commitment”
Stay updated with Hemostasis Today.
-
Sep 30, 2025, 11:43Wolfgang Miesbach: Jan Astermark at the BIC 2025 Presented Potentially the First Oral FVIII Mimetic Treatment for Hemophilia A
-
Sep 30, 2025, 06:43Sara García Barcenilla: What Better Way to Celebrate ''World ITP Day'' Then With The Interview of Nora Butta and Daniel Aníbal García-Diego
-
Sep 30, 2025, 06:42Courtney Battaglia: AFib Can Cause Racing Heartbeat or Fatigue and Also Raises The Risk of Stroke!
-
Sep 29, 2025, 22:44Pall T. Onundarson on Correlation Between Plasma Levels of DOACs and Both Thromboembolic and Bleeding Events
-
Sep 29, 2025, 16:19Xue Feng Presented Her Work on AAV Vector–Based Gene Therapy
-
Sep 30, 2025, 06:45Robert Mikulik and Colleagues Show Differences in Acute Ischemic Stroke Treatment
-
Sep 30, 2025, 06:40Cihan Ay: Can AI Match Thrombosis Experts?
-
Sep 29, 2025, 19:56Luisa Hora de Carvalho and Colleagues Highlight The Challenges in Evaluating Thromboembolic Risk in Acute Leukemia
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 11:48Nan van Geloven on Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 19:39Louise Bannon: Today is World Heart Day, And It's Deeply Personal For Me
-
Sep 29, 2025, 16:16Maxime Dely: Improving Collections for Better Patient Outcomes
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Sep 30, 2025, 06:40
Sep 29, 2025, 21:11
Sep 29, 2025, 19:39
Sep 29, 2025, 16:19
Sep 29, 2025, 16:16
Sep 29, 2025, 12:54